FDAnews
www.fdanews.com/articles/181267-fda-clears-roche-cintec-histology-test
roche.gif

FDA Clears Roche CINtec Histology Test

April 7, 2017

Roche has received FDA marketing clearance for the CINtec Histology test. The p16 biomarker test, when used in conjunction with hematoxylin & eosin (H&E) staining, helps pathologists determine which women should receive treatment for cervical pre-cancer.

The test is a part of Roche’s cervical cancer portfolio, which also includes the Cobas HPV test and the CINtec plus cytology3 test.

The clearance was based on the results from a clinical study demonstrating the effectiveness of the portfolio.  — Cynthia Jessup

View today's stories